Tag: breast cancer

May 23, 2018

Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO

The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
May 22, 2018

5 Top Weekly NASDAQ Biotech Stocks: Vivus on Top

Eiger BioPharmaceuticals, ArQule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences, were last week's top gainers on the NASDAQ.
May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of...
May 7, 2018

Rexahn Reports First Quarter 2018 Financial Results

Rexahn Pharmaceuticals (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced financial...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 29, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 27, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 26, 2018

Merus Announces Recent Corporate Developments and Financial Results for the Fourth Quarter and Full Year 2017

Merus (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced financial results for the fourth quarter...